SMT201400112B - Composizioni per trattare nausea e vomito mediati a livello centrale - Google Patents

Composizioni per trattare nausea e vomito mediati a livello centrale

Info

Publication number: SMT201400112B
Authority: SM; San Marino
Prior art keywords: vomiting; treat; compositions; centrally mediated; nausea
Prior art date: 2009-11-18

Application number

SM201400112T

Other languages

English (en)

Italian (it)

Inventor

Fabio Trento

Giorgia Rossi

Daniele Bonadeo

Sergio Cantoreggi

Roberta Cannella

Riccardo Braglia

Original Assignee

Helsinn Healthcare Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-18

Filing date

2014-08-18

Publication date

2014-11-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43608757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201400112(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-08-18 Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa

2014-11-10 Publication of SMT201400112B publication Critical patent/SMT201400112B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Paints Or Removers (AREA)

SM201400112T 2009-11-18 2014-08-18 Composizioni per trattare nausea e vomito mediati a livello centrale SMT201400112B (it)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US26247009P	2009-11-18	2009-11-18
US38270910P	2010-09-14	2010-09-14
PCT/IB2010/003106 WO2011061622A1 (fr)	2009-11-18	2010-11-18	Compositions pour traiter les nausées et vomissements à médiation centrale

Publications (1)

Publication Number	Publication Date
SMT201400112B true SMT201400112B (it)	2014-11-10

Family

ID=43608757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM201400112T SMT201400112B (it)	2009-11-18	2014-08-18	Composizioni per trattare nausea e vomito mediati a livello centrale

Country Status (40)

Country	Link
US (1)	US12042494B2 (fr)
EP (3)	EP2727590B1 (fr)
JP (1)	JP5890780B2 (fr)
KR (1)	KR101615108B1 (fr)
CN (6)	CN107050455B (fr)
AP (1)	AP3083A (fr)
AU (1)	AU2010320598B2 (fr)
BR (1)	BR112012011485B1 (fr)
CA (1)	CA2778301C (fr)
CL (1)	CL2012001276A1 (fr)
CO (1)	CO6551693A2 (fr)
CR (1)	CR20120216A (fr)
CU (1)	CU24048B1 (fr)
CY (1)	CY1118062T1 (fr)
DK (2)	DK2361090T3 (fr)
DO (1)	DOP2012000138A (fr)
EA (1)	EA026815B1 (fr)
EC (1)	ECSP12011907A (fr)
ES (4)	ES2559475T3 (fr)
GE (1)	GEP20156226B (fr)
GT (1)	GT201200156A (fr)
HK (2)	HK1214147A1 (fr)
HR (3)	HRP20140759T1 (fr)
HU (1)	HUE029677T2 (fr)
IL (1)	IL219576A (fr)
LT (1)	LT2722045T (fr)
MA (1)	MA33810B1 (fr)
MX (1)	MX2012005347A (fr)
MY (1)	MY159393A (fr)
NI (1)	NI201200090A (fr)
NZ (1)	NZ599439A (fr)
PE (1)	PE20121483A1 (fr)
PH (1)	PH12012500887A1 (fr)
PL (3)	PL2722045T3 (fr)
PT (2)	PT2361090E (fr)
RS (2)	RS53491B1 (fr)
SI (2)	SI2361090T1 (fr)
SM (1)	SMT201400112B (fr)
TN (1)	TN2012000170A1 (fr)
WO (1)	WO2011061622A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2722045B1 (fr)	2009-11-18	2016-07-06	Helsinn Healthcare SA	Compositions pour traiter les nausées et vomissements à médiation centrale
LT2722045T (lt)	2009-11-18	2016-09-26	Helsinn Healthcare Sa	Kompozicija skirta gydyti centralizuotai kontroliuojamą pykinimą ir vėmimą
WO2013004766A1 (fr) *	2011-07-04	2013-01-10	Ferrari Giulio	Antagonistes des récepteurs nk-1 pour traiter une néovascularisation cornéenne
JP2014530249A (ja) *	2011-10-18	2014-11-17	ヘルシンヘルスケアソシエテアノニム	ネツピタントおよびパロノセトロンの治療学的組合せ
US8426450B1 (en) *	2011-11-29	2013-04-23	Helsinn Healthcare Sa	Substituted 4-phenyl pyridines having anti-emetic effect
US9403772B2 (en)	2011-11-29	2016-08-02	Helsinn Healthcare Sa	4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator
CN103520725B (zh) *	2012-07-05	2017-10-24	海思科医药集团股份有限公司	一种治疗呕吐的药物组合物
CA3213864A1 (fr)	2015-03-04	2016-09-09	Vanda Pharmaceuticals Inc.	Regime posologique de tradipitant
CN106902086B (zh) *	2015-12-23	2020-10-20	江苏恒瑞医药股份有限公司	一种包含奈妥匹坦的固体组合物
GB201618425D0 (en) *	2016-11-01	2016-12-14	Acacia Pharma Ltd	method
GB201702250D0 (en)	2017-02-10	2017-03-29	Acacia Pharma Ltd	Method
CN108721214B (zh) *	2017-04-14	2020-06-16	和龙	奈妥吡坦和帕洛诺司琼复方纳米粒溶液、纳米粒及制备方法和用途
CN108853010A (zh) *	2017-05-15	2018-11-23	和龙	奈妥吡坦环糊精包合物、复方组合制剂及其制备方法和用途
CN109200018A (zh) *	2017-07-04	2019-01-15	南京诺瑞特医药科技有限公司	含有奈妥吡坦的微乳制剂
FI3710000T3 (fi) *	2017-11-17	2025-07-03	Vanda Pharmaceuticals Inc	Tradipitantti käytettäväksi gastropareesin hoidossa
JP2021512869A (ja) *	2018-02-02	2021-05-20	ユーストラリスファーマシューティカルズリミテッド（トレーディングアズプレススラニューロ）	経口製剤及びその使用
MX2023007578A (es) *	2020-12-25	2023-07-06	Shanghai Shengdi Pharmaceutical Co Ltd	Uso del compuesto profarmaco antagonista nk1 en combinacion con un antagonista del receptor 5-ht3.
EP4385497A1 (fr)	2022-12-12	2024-06-19	Alfred E. Tiefenbacher (GmbH & Co. KG)	Combinaison de doses fixes sans antioxydant de nétupitant et de palonosétron
IL321446A (en)	2022-12-12	2025-08-01	Tiefenbacher Alfred E Gmbh & Co Kg	Fixed-dose combination including netopitant and flunosterone
EP4385500A1 (fr)	2022-12-12	2024-06-19	Alfred E. Tiefenbacher (GmbH & Co. KG)	Combinaison de doses fixes comprenant du nétupitant et du palonosétron
EP4633608A1 (fr)	2022-12-12	2025-10-22	Alfred E. Tiefenbacher (GmbH & Co. KG)	Association de dose fixe sans antioxydant de netupitant et de palonosétron

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI98367C (fi)	1989-11-28	1997-06-10	Syntex Inc	Menetelmä uusien terapeuttisesti käyttökelpoisten trisyklisten, typpipitoisten yhdisteiden valmistamiseksi
US5510486A (en)	1994-07-26	1996-04-23	Syntex (U.S.A.) Inc.	Process for preparing 2-(1-azabicyclo 2.2.2!oct-3-yl)-2,3,3A,4,5,6-hexahydro-1H-benz de!isoquinolin-1-one
US6297395B1 (en)	1995-11-10	2001-10-02	The Secretary Of State For Defence In Her Brittanic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland	Calixarenes and their use for sequestration of metals
DK1394150T3 (da)	1999-02-24	2011-03-21	Hoffmann La Roche	4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
NZ523273A (en)	2000-07-14	2004-08-27	F	N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
ES2272408T3 (es)	2000-12-14	2007-05-01	F. Hoffmann-La Roche Ag	Matriz lipidica autoemulsificante (selm).
DE10393729T5 (de)	2002-11-15	2005-10-13	Helsinn Healthcare S.A.	Verfahren zur Behandlung von Emesis
JO2735B1 (en)	2003-01-30	2013-09-15	هيلسين هيلث كير أس ايه.	Liquid pharmaceutical formations of balloonosterone
TWI355936B (en) *	2003-02-18	2012-01-11	Helsinn Healthcare Sa	Uses of palonosetron hydrochloride
JP2006522817A (ja) *	2003-04-08	2006-10-05	プロジェニックスファーマシューティカルズ，インコーポレーテッド	過敏性腸症候群を処置するための末梢オピオイドアンタゴニスト、特にメチルナルトレキソンの使用
WO2006089674A2 (fr)	2005-02-25	2006-08-31	F.Hoffmann-La Roche Ag	Comprimés présentant une dispersibilité de substance médicamenteuse améliorée
US7479312B2 (en)	2005-07-07	2009-01-20	Konica Minolta Opto, Inc.	Retardation film, polarizing plate, and liquid crystal display device
US8158152B2 (en) *	2005-11-18	2012-04-17	Scidose Llc	Lyophilization process and products obtained thereby
BRPI0708264A2 (pt)	2006-02-23	2011-05-24	Pfizer Ltd	piperidinilpirrolidinas agonistas do receptor tipo 4 de melanocortina
SI1940366T1 (sl) *	2006-10-24	2009-08-31	Helsinn Healthcare Sa	Mehke kapsule, ki obsegajo palonosetron hidroklorid, z izboljĹˇano stabilnostjo in biorazpoloĹľljivostjo
WO2009005673A1 (fr) *	2007-06-28	2009-01-08	Schering Corporation	Anti-igf1r
WO2009079587A2 (fr) *	2007-12-18	2009-06-25	Schering Corporation	Biomarqueurs de sensibilité à une thérapie anti-igf1r
LT2722045T (lt)	2009-11-18	2016-09-26	Helsinn Healthcare Sa	Kompozicija skirta gydyti centralizuotai kontroliuojamą pykinimą ir vėmimą

2010
- 2010-11-18 LT LTEP14151683.1T patent/LT2722045T/lt unknown
- 2010-11-18 SI SI201030688T patent/SI2361090T1/sl unknown
- 2010-11-18 PL PL14151683T patent/PL2722045T3/pl unknown
- 2010-11-18 BR BR112012011485-9A patent/BR112012011485B1/pt active IP Right Grant
- 2010-11-18 MX MX2012005347A patent/MX2012005347A/es active IP Right Grant
- 2010-11-18 ES ES14151676.5T patent/ES2559475T3/es active Active
- 2010-11-18 EP EP14151676.5A patent/EP2727590B1/fr active Active
- 2010-11-18 PT PT108053018T patent/PT2361090E/pt unknown
- 2010-11-18 RS RSP20140423 patent/RS53491B1/sr unknown
- 2010-11-18 JP JP2012539433A patent/JP5890780B2/ja active Active
- 2010-11-18 DK DK10805301.8T patent/DK2361090T3/da active
- 2010-11-18 AU AU2010320598A patent/AU2010320598B2/en active Active
- 2010-11-18 CN CN201610795817.1A patent/CN107050455B/zh active Active
- 2010-11-18 DK DK14151683.1T patent/DK2722045T3/en active
- 2010-11-18 CN CN2010800521070A patent/CN102655864A/zh active Pending
- 2010-11-18 PE PE2012000686A patent/PE20121483A1/es active IP Right Grant
- 2010-11-18 ES ES14151678.1T patent/ES2623503T3/es active Active
- 2010-11-18 CA CA2778301A patent/CA2778301C/fr active Active
- 2010-11-18 PT PT141516831T patent/PT2722045T/pt unknown
- 2010-11-18 EP EP14151678.1A patent/EP2722044B1/fr active Active
- 2010-11-18 MY MYPI2012002073A patent/MY159393A/en unknown
- 2010-11-18 EP EP10805301.8A patent/EP2361090B1/fr active Active
- 2010-11-18 PL PL10805301T patent/PL2361090T3/pl unknown
- 2010-11-18 NZ NZ599439A patent/NZ599439A/en unknown
- 2010-11-18 ES ES10805301.8T patent/ES2494015T3/es active Active
- 2010-11-18 HU HUE14151683A patent/HUE029677T2/hu unknown
- 2010-11-18 CN CN201610795827.5A patent/CN106421793B/zh active Active
- 2010-11-18 PH PH1/2012/500887A patent/PH12012500887A1/en unknown
- 2010-11-18 CN CN201510046972.9A patent/CN104856998A/zh active Pending
- 2010-11-18 GE GEAP201012752A patent/GEP20156226B/en unknown
- 2010-11-18 RS RS20160833A patent/RS55206B1/sr unknown
- 2010-11-18 SI SI201031291T patent/SI2722045T1/sl unknown
- 2010-11-18 CN CN201610797549.7A patent/CN106512010A/zh active Pending
- 2010-11-18 AP AP2012006278A patent/AP3083A/xx active
- 2010-11-18 KR KR1020127015676A patent/KR101615108B1/ko active Active
- 2010-11-18 HR HRP20140759AT patent/HRP20140759T1/hr unknown
- 2010-11-18 PL PL14151678T patent/PL2722044T3/pl unknown
- 2010-11-18 ES ES14151683.1T patent/ES2595077T3/es active Active
- 2010-11-18 EA EA201290356A patent/EA026815B1/ru active Protection Beyond IP Right Term
- 2010-11-18 WO PCT/IB2010/003106 patent/WO2011061622A1/fr not_active Ceased
- 2010-11-18 CN CN201510047631.3A patent/CN104856999A/zh active Pending
2012
- 2012-04-13 TN TNP2012000170A patent/TN2012000170A1/en unknown
- 2012-04-26 CR CR20120216A patent/CR20120216A/es unknown
- 2012-05-03 IL IL219576A patent/IL219576A/en active IP Right Grant
- 2012-05-10 NI NI201200090A patent/NI201200090A/es unknown
- 2012-05-15 DO DO2012000138A patent/DOP2012000138A/es unknown
- 2012-05-16 CL CL2012001276A patent/CL2012001276A1/es unknown
- 2012-05-17 EC ECSP12011907 patent/ECSP12011907A/es unknown
- 2012-05-18 CU CU2012000078A patent/CU24048B1/es active IP Right Grant
- 2012-05-18 CO CO12082329A patent/CO6551693A2/es not_active Application Discontinuation
- 2012-05-18 GT GT201200156A patent/GT201200156A/es unknown
- 2012-06-11 MA MA34953A patent/MA33810B1/fr unknown
2014
- 2014-08-18 SM SM201400112T patent/SMT201400112B/xx unknown
2016
- 2016-02-24 HK HK16102109.6A patent/HK1214147A1/zh unknown
- 2016-02-24 HK HK16102110.3A patent/HK1214148A1/zh unknown
- 2016-10-05 HR HRP20161277TT patent/HRP20161277T1/hr unknown
- 2016-10-05 CY CY20161100991T patent/CY1118062T1/el unknown
2017
- 2017-03-14 HR HRP20170419TT patent/HRP20170419T1/hr unknown
2022
- 2022-12-16 US US18/082,737 patent/US12042494B2/en active Active

Also Published As

Publication number	Publication date
LT2722045T (lt)	2016-09-26
HRP20161277T1 (hr)	2016-11-18
CL2012001276A1 (es)	2012-12-07
HK1214147A1 (zh)	2016-07-22
NZ599439A (en)	2014-06-27
SI2722045T1 (sl)	2017-02-28
PH12012500887A1 (en)	2016-08-26
JP2013511507A (ja)	2013-04-04
TN2012000170A1 (en)	2013-12-12
BR112012011485A2 (pt)	2018-04-03
CY1118062T1 (el)	2017-06-28
EP2361090A1 (fr)	2011-08-31
EP2722044A1 (fr)	2014-04-23
EP2722044B1 (fr)	2017-01-04
GT201200156A (es)	2014-03-27
HUE029677T2 (hu)	2017-03-28
EP2727590A1 (fr)	2014-05-07
DOP2012000138A (es)	2012-11-15
GEP20156226B (en)	2015-01-26
PL2722044T3 (pl)	2017-08-31
ES2559475T3 (es)	2016-02-12
CN106421793B (zh)	2023-06-16
CN107050455B (zh)	2020-09-29
SI2361090T1 (sl)	2014-09-30
AU2010320598A1 (en)	2012-06-14
CA2778301A1 (fr)	2011-05-26
IL219576A0 (en)	2012-06-28
CA2778301C (fr)	2016-06-14
PL2722045T3 (pl)	2017-03-31
HRP20140759T1 (hr)	2014-10-24
EP2361090B1 (fr)	2014-05-21
CN107050455A (zh)	2017-08-18
HK1214148A1 (zh)	2016-07-22
US20230263799A1 (en)	2023-08-24
PE20121483A1 (es)	2012-12-02
CN104856999A (zh)	2015-08-26
WO2011061622A1 (fr)	2011-05-26
BR112012011485B1 (pt)	2021-06-29
ECSP12011907A (es)	2012-10-30
IL219576A (en)	2017-08-31
RS55206B1 (sr)	2017-01-31
DK2722045T3 (en)	2016-10-24
MA33810B1 (fr)	2012-12-03
HRP20170419T1 (hr)	2017-06-02
ES2494015T3 (es)	2014-09-12
AP3083A (en)	2015-01-31
CN104856998A (zh)	2015-08-26
KR20120101456A (ko)	2012-09-13
EA201290356A1 (ru)	2012-12-28
ES2595077T3 (es)	2016-12-27
CN106421793A (zh)	2017-02-22
JP5890780B2 (ja)	2016-03-22
RS53491B1 (sr)	2015-02-27
CR20120216A (es)	2012-07-24
US12042494B2 (en)	2024-07-23
NI201200090A (es)	2012-11-13
CN106512010A (zh)	2017-03-22
CU20120078A7 (es)	2012-10-15
CO6551693A2 (es)	2012-10-31
PT2361090E (pt)	2014-09-03
EP2727590B1 (fr)	2015-10-21
KR101615108B1 (ko)	2016-05-12
PL2361090T3 (pl)	2014-10-31
AP2012006278A0 (en)	2012-06-30
AU2010320598B2 (en)	2016-06-16
CN102655864A (zh)	2012-09-05
CU24048B1 (es)	2014-12-26
DK2361090T3 (da)	2014-08-25
MY159393A (en)	2016-12-30
PT2722045T (pt)	2016-10-18
EA026815B1 (ru)	2017-05-31
ES2623503T3 (es)	2017-07-11
MX2012005347A (es)	2012-08-03

Publication	Publication Date	Title
SMT201400112B (it)	2014-11-10	Composizioni per trattare nausea e vomito mediati a livello centrale
SMT201600427B (it)	2017-01-10	Composizioni per trattare nausea e vomito mediati a livello centrale
HUE048001T2 (hu)	2020-05-28	Óceán által hajtott erõmû
ZA201006559B (en)	2012-07-25	Methods to produce stretchable products
DK3078664T3 (da)	2019-05-13	Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (fr)	2014-02-19	Compositions
UY33161A (es)	2011-07-29	Composiciones plaguicidas
EP2298585A4 (fr)	2011-08-03	Groupe motopropulseur
PL2659771T3 (pl)	2019-05-31	Rośliny transgeniczne o zwiększonej biomasie
BRPI1010690A2 (pt)	2016-03-15	composições
BRPI1013383A2 (pt)	2015-09-01	Goma xantana aperfeiçoada
GB201002671D0 (en)	2010-04-07	Improvements to toy building blocks
DE112010004236A5 (de)	2012-10-18	Wasserkraftanlage
BR112012002281A2 (pt)	2016-06-14	composicoes poliofinicas
HUE032978T2 (hu)	2017-11-28	Pemirolaszt kristályos formában
DE112010002033B8 (de)	2017-06-01	Biohydrofuel-Zusammensetzungen
FR2947288B1 (fr)	2013-07-05	Spatule a lisser
NO20093380A1 (no)	2011-03-07	Anlegg for å produsere energi
FR2950528B1 (fr)	2011-10-28	Composition amincissante
BR112012002292A2 (pt)	2016-06-14	composições poliofínicas
DE112009005304A5 (de)	2012-08-02	Segelkraftwerk
BRPI1011570A2 (pt)	2016-04-05	composições
AT508614A3 (de)	2011-05-15	Kompaktenergieanlage
ZA201203174B (en)	2013-02-27	Compositions for treating centrally mediated nausea and vomiting
FI20096023A0 (fi)	2009-10-06	Pienvoimalaitos